Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
Clinical trial NCT04152486 · UNKNOWN
Trial details
- NCT number
- NCT04152486
- Sponsor
- London School of Hygiene and Tropical Medicine
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-14
- Primary completion
- 2022-01-31
- Enrollment
- 20426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.